Bangladesh reported 321,179 dengue cases and at least 1,705 deaths in 2023, the worst single-country outbreak in recorded history. PandemicAlarm rates dengue's current global situation at severity 3/5. Not because any single outbreak threatens pandemic-scale catastrophe, but because the disease's geographic range is expanding faster than any other vector-borne illness and available countermeasures remain limited.

Half the world's population now lives in areas where dengue transmission is possible. WHO estimates 100-400 million infections occur annually, though most go undiagnosed. What was once confined to a handful of tropical countries now reaches southern Europe, the southern United States, and parts of Australia.

What happened in Bangladesh?

All four dengue serotypes (DENV-1 through DENV-4) circulated simultaneously during Bangladesh's 2023 outbreak — a phenomenon that dramatically increases the risk of severe disease. When you're infected with one serotype, you develop lifelong immunity to that serotype but only temporary cross-protection against the other three. A second infection with a different serotype triggers antibody-dependent enhancement (ADE), where your immune system's antibodies from the first infection actually help the new virus enter cells more efficiently.

ADE is why dengue kills. First infections are usually mild. Second infections with a different serotype can progress to dengue hemorrhagic fever or dengue shock syndrome, both of which carry fatality rates of 2-5% even with hospital care.

Bangladesh's healthcare system buckled under the case load. Hospitals in Dhaka ran out of beds. Rural clinics lacked the IV fluids needed for severe cases. The 1,705 official death count is almost certainly an undercount because community deaths in rural areas often go unreported.

Prior to 2023, Bangladesh's worst dengue year was 2019 with 101,354 cases. The threefold increase reflects both expanding mosquito populations and accumulated immunity gaps. A generation of Bangladeshis who survived mild first infections were primed for severe second infections when new serotypes swept through.

Why is dengue spreading to new places?

Aedes aegypti, the primary mosquito vector for dengue, is following rising temperatures into previously inhospitable territory. This mosquito needs sustained temperatures above 18C to complete its life cycle. As average temperatures climb, that threshold is being crossed in new latitudes every year.

Southern Europe is already seeing results. France reported 65 locally acquired dengue cases in 2023, all from the Aedes albopictus mosquito (the secondary vector) that has established permanent populations along the Mediterranean coast. Italy, Spain, and Croatia have reported similar autochthonous transmission: cases with no travel history, meaning the virus is circulating locally.

In the Americas, dengue's range is pushing further from the equator. Argentina experienced its largest-ever outbreak in early 2024 with over 400,000 cases. Southern US states including Texas and Florida report small clusters of local transmission annually, and Aedes aegypti populations are established as far north as parts of Tennessee and North Carolina.

By 2050, climate models project that an additional 2.25 billion people will be newly exposed to dengue transmission risk, primarily in East Asia, sub-Saharan Africa, and higher-elevation regions that were previously too cool for Aedes mosquitoes to survive.

Is there a vaccine?

Two dengue vaccines exist, but neither solves the problem for most people.

Dengvaxia (Sanofi) was the first licensed dengue vaccine but comes with a critical limitation: it can increase the risk of severe disease in people who haven't been previously infected with dengue. The Philippines vaccinated over 800,000 schoolchildren with Dengvaxia in 2016-2017 before this risk was fully understood. An estimated 600 excess deaths may have resulted. WHO now recommends Dengvaxia only for individuals with confirmed prior dengue infection, which limits its usefulness for mass vaccination campaigns.

Qdenga (Takeda) received WHO prequalification in 2024 and appears safer for dengue-naive individuals, though long-term data on protection against all four serotypes is still accumulating. Supply is limited, and the 2-dose regimen requires a 3-month gap between doses, complicating delivery in outbreak settings.

Neither vaccine is widely available for international travelers. If you're heading to an area tracked on PandemicAlarm with active dengue transmission, vaccination is unlikely to be your primary protection.

How do you protect yourself?

Personal protection against dengue comes down to one thing: avoiding mosquito bites. Aedes aegypti is a daytime biter that feeds primarily in the early morning and late afternoon, so bed nets alone won't protect you.

DEET-based repellents (20-30% concentration) provide 6-8 hours of protection and remain the gold standard. Picaridin (20%) is an effective alternative with less skin irritation. Oil of lemon eucalyptus (30% p-menthane-3,8-diol) provides moderate protection for 4-6 hours.

Permethrin-treated clothing kills mosquitoes on contact and remains effective through 6-8 washes. Treating long-sleeved shirts and pants creates a barrier that dramatically reduces bite rates even without repellent on exposed skin.

Eliminate standing water around your living space. Aedes aegypti breeds in tiny water collections. A bottle cap holds enough water to produce mosquito larvae. Flower pot saucers, clogged gutters, old tires, and uncovered water storage containers are common breeding sites. One study in Dhaka found that covering household water containers reduced local dengue incidence by 30%.

Check the disease risks by region page on PandemicAlarm before travel to confirm whether your destination has active dengue transmission. Peak transmission follows rainy seasons, which vary by geography.

What should you watch for?

Dengue symptoms appear 4-10 days after a bite: sudden high fever (often 40C+), severe headache behind the eyes, joint and muscle pain, nausea, and a rash appearing 2-5 days after fever onset. Most cases resolve in a week with rest and fluids. Acetaminophen for fever. Avoid aspirin and ibuprofen, which increase bleeding risk.

Warning signs of severe dengue typically emerge 24-48 hours after fever breaks: persistent vomiting, abdominal pain, bleeding gums, blood in vomit or stool, and rapid breathing. Severe dengue requires immediate hospital care with IV fluid management. If you're in an endemic area and fever drops suddenly while you feel worse, not better, get to a medical facility immediately.

PandemicAlarm tracks dengue outbreaks globally, including case counts and geographic spread patterns. Dengue isn't new. What's new is where it's going — and the 2.25 billion additional people who will be living in transmission zones within a generation.